Thursday - October 08, 2026

Category Archives: Science

Diabetic Macular Edema Market is Projected to Grow by 2036 Owing to Rising Diabetes Burden and Advancements in Long-Acting Retinal Therapies | DelveInsight

The market dynamics for Diabetic Macular Edema are witnessing steady growth driven by the increasing prevalence of diabetes, growing disease burden, improvements in retinal screening and diagnosis, continued dominance of anti-VEGF therapies, and increasing adoption of long-acting and sustained-delivery treatments. … Continue reading →

Dravet Syndrome Market is Projected to Grow by 2036 Owing to Rising Diagnosis and Advancements in Gene-Targeted Therapies | DelveInsight

The market dynamics for Dravet syndrome are witnessing steady growth, driven by increasing disease awareness, improvements in genetic testing and diagnosis, growing adoption of targeted anti-seizure therapies, and continued investment in precision and disease-modifying approaches. The therapeutic landscape is gradually … Continue reading →

Duchenne Muscular Dystrophy Market is Projected to Grow at an 11% CAGR by 2036 Owing to the Advancement of Gene Therapies and Disease-Modifying Treatments | DelveInsight

The market dynamics for Duchenne Muscular Dystrophy (DMD) are witnessing significant growth driven by increasing genetic screening and diagnosis, advancements in exon-skipping and gene-replacement therapies, a strong clinical development pipeline, growing regulatory support for rare-disease therapies, and increasing healthcare investment. … Continue reading →

Liver Cancer Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The Liver Cancer Clinical Trials analysis report delivers important insights into ongoing research on 70+ pipeline Liver Cancer Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 07, 2026, DelveInsight’s “Liver Cancer Pipeline Insight 2026” report provides … Continue reading →

Lou Gehrig’s Disease Clinical Trial Pipeline Gains Momentum: 75+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Lou Gehrig’s Disease Clinical Trials analysis report delivers important insights into ongoing research on 75+ pipeline Lou Gehrig’s Disease Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 07, 2026 – DelveInsight’s “Lou Gehrig’s disease Pipeline … Continue reading →

Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Metastatic Castration-Resistant Prostate Cancer Clinical Trials analysis report delivers important insights into ongoing research on 75+ pipeline Metastatic Castration-Resistant Prostate Cancer Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 07, 2026, DelveInsight’s “Metastatic Castration-Resistant Prostate … Continue reading →

Metastatic Breast Cancer Clinical Trial Drug Development Pipeline Expands with Contributions from 100+ Key Companies | DelveInsight

The Metastatic Breast Cancer Clinical Trials analysis report delivers important insights into ongoing research on 100+ pipeline Metastatic Breast Cancer Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 07, 2026, DelveInsight’s “Metastatic Breast Cancer Pipeline Insights … Continue reading →

Metastatic Prostate Cancer Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Metastatic Prostate Cancer clinical trial analysis report delivers important insights into ongoing research of 80+ pipeline Metastatic Prostate Cancer drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 07, 2026, DelveInsight’s, “Metastatic Prostate Cancer Pipeline Insights … Continue reading →